{"id":"long-course-chemotherapy","safety":{"commonSideEffects":[{"rate":"50-80%","effect":"Nausea"},{"rate":"30-60%","effect":"Fatigue"},{"rate":"20-50%","effect":"Hair loss"},{"rate":"10-30%","effect":"Anemia"},{"rate":"5-20%","effect":"Neutropenia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This approach allows for higher doses of chemotherapy to be administered, increasing the likelihood of killing cancer cells while minimizing damage to healthy cells. However, it also increases the risk of side effects and toxicity.","oneSentence":"Long-course chemotherapy involves administering chemotherapy drugs over an extended period to target and kill cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:19:21.224Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of various cancers"}]},"trialDetails":[{"nctId":"NCT07458100","phase":"NA","title":"The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders","status":"RECRUITING","sponsor":"Peking University","startDate":"2026-03","conditions":"Emotional Disorders, Depressive Disorder, Anxiety Disorders","enrollment":464},{"nctId":"NCT03486873","phase":"PHASE3","title":"Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-08-21","conditions":"Solid Tumors, Hematologic Malignancies","enrollment":3500},{"nctId":"NCT07448077","phase":"PHASE2","title":"Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC","status":"NOT_YET_RECRUITING","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2026-03-01","conditions":"Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer","enrollment":128},{"nctId":"NCT07444918","phase":"PHASE2","title":"Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2026-03-01","conditions":"Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma)","enrollment":33},{"nctId":"NCT04928807","phase":"PHASE3","title":"Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2021-07-20","conditions":"Rectal Cancer","enrollment":231},{"nctId":"NCT06361914","phase":"NA","title":"Digital CBT-I for Patients With Chronic Pain and Insomnia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Odense University Hospital","startDate":"2024-04-12","conditions":"Chronic Pain, Insomnia","enrollment":140},{"nctId":"NCT06459869","phase":"PHASE1","title":"NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Akamis Bio","startDate":"2025-04-07","conditions":"Locally Advanced Rectal Cancer (LARC)","enrollment":30},{"nctId":"NCT07113275","phase":"PHASE3","title":"A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Tao Zhang","startDate":"2026-02-11","conditions":"Rectal Cancer, Total Neoadjuvant Therapy, Radiotherapy","enrollment":435},{"nctId":"NCT07381777","phase":"PHASE2","title":"XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients","status":"NOT_YET_RECRUITING","sponsor":"Gruppo Oncologico Italiano di Ricerca Clinica","startDate":"2026-01-31","conditions":"Locally Advanced Rectal Cancer (LARC)","enrollment":270},{"nctId":"NCT07372300","phase":"PHASE3","title":"Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Shih-Kai Hung","startDate":"2025-09-23","conditions":"Locally Advanced Rectal Carcinoma","enrollment":126},{"nctId":"NCT06089083","phase":"","title":"PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-10-18","conditions":"Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm","enrollment":500},{"nctId":"NCT04539808","phase":"PHASE2","title":"NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2021-05-27","conditions":"Pancreatic Adenocarcinoma, Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8, Stage I Pancreatic Cancer American Joint Committee on Cancer v8","enrollment":42},{"nctId":"NCT06124118","phase":"PHASE1","title":"Tumor Treating Fields for Locally Advanced NSCLC","status":"RECRUITING","sponsor":"University of Utah","startDate":"2024-04-04","conditions":"Non Small Cell Lung Cancer","enrollment":30},{"nctId":"NCT07314385","phase":"PHASE1","title":"NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2026-01-01","conditions":"Pancreatic Adenocarcinoma Metastatic, Liver Metastasis","enrollment":24},{"nctId":"NCT07284992","phase":"PHASE2","title":"SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC","status":"RECRUITING","sponsor":"Shandong Provincial Hospital","startDate":"2025-09-12","conditions":"Rectal Cancer, Advanced Stage Colorectal Cancer, Radiotherapy","enrollment":208},{"nctId":"NCT07277842","phase":"PHASE3","title":"PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-12-29","conditions":"Locally Advanced Low Rectal Adenocarcinoma, pMMR (Microsatellite Stable Rectal Cancer)","enrollment":382},{"nctId":"NCT06052332","phase":"NA","title":"Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2024-02-07","conditions":"Locally Advanced Rectal Cancer, Older People","enrollment":230},{"nctId":"NCT07258797","phase":"NA","title":"Short Course or Long Course Radiotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Rajiv Gandhi Cancer Institute & Research Center, India","startDate":"2025-12-01","conditions":"Adenocarcinoma of the Rectum","enrollment":150},{"nctId":"NCT07248020","phase":"PHASE2","title":"A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-01-01","conditions":"Rectal Cancer, Locally Advanced Rectal Cancer, Radiation-Induced Enteritis","enrollment":72},{"nctId":"NCT04443348","phase":"PHASE2","title":"Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Laura M. Spring, MD","startDate":"2020-12-16","conditions":"Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph Node(s)","enrollment":120},{"nctId":"NCT07200141","phase":"PHASE2","title":"Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-10-01","conditions":"Locally Advanced Rectal Adenocarcinoma","enrollment":156},{"nctId":"NCT07194616","phase":"NA","title":"Rectal Cancer CTC Trial","status":"RECRUITING","sponsor":"University Hospital Ostrava","startDate":"2025-04-01","conditions":"Rectal Cancer Patients","enrollment":120},{"nctId":"NCT05471700","phase":"NA","title":"Single Arm Study of Azacitidine and Venetoclax for Treatment of Newly Diagnosed Fit Acute Myeloid Leukemia Patients","status":"COMPLETED","sponsor":"Zhujiang Hospital","startDate":"2022-09-01","conditions":"Leukemia, Myeloid, Acute","enrollment":40},{"nctId":"NCT07161115","phase":"PHASE2","title":"Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Longhao Li","startDate":"2025-09-19","conditions":"Rectal Adenocarcinoma","enrollment":60},{"nctId":"NCT05610163","phase":"PHASE2","title":"Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2022-12-08","conditions":"Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8","enrollment":783},{"nctId":"NCT07154316","phase":"PHASE2","title":"Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-08-01","conditions":"Colorectal Cancer","enrollment":138},{"nctId":"NCT06770270","phase":"PHASE2","title":"Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-08-01","conditions":"Rectal Cancer","enrollment":68},{"nctId":"NCT07150949","phase":"PHASE2","title":"Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-08-28","conditions":"Locally Advanced Rectal Cancer, Neoadjuvant Therapy","enrollment":138},{"nctId":"NCT07137858","phase":"PHASE2","title":"Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-08-15","conditions":"Oral Squamous Cell Carcinoma (OSCC), Neoadjuvant Chemoimmunotherapy","enrollment":70},{"nctId":"NCT07132463","phase":"PHASE3","title":"Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-08","conditions":"Rectal Cancer","enrollment":154},{"nctId":"NCT07057089","phase":"PHASE2","title":"Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)","status":"RECRUITING","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2025-07-01","conditions":"Locally Advanced Rectal Cancer","enrollment":90},{"nctId":"NCT05254327","phase":"PHASE2","title":"Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2022-08-15","conditions":"Rectal Cancer","enrollment":118},{"nctId":"NCT07108530","phase":"PHASE2","title":"Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-08-06","conditions":"Acute Myeloid Leukemia","enrollment":50},{"nctId":"NCT06262438","phase":"PHASE2","title":"CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients","status":"RECRUITING","sponsor":"Princess Maxima Center for Pediatric Oncology","startDate":"2024-02-06","conditions":"Acute Myeloid Leukemia in Children","enrollment":60},{"nctId":"NCT07074353","phase":"PHASE3","title":"Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2025-07-20","conditions":"Locally Advanced Rectal Cancer","enrollment":360},{"nctId":"NCT07040098","phase":"PHASE2","title":"Optimizing Immunotherapy Combined With Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2025-06-01","conditions":"Locally Advanced Rectal Cancer (LARC)","enrollment":228},{"nctId":"NCT06850090","phase":"PHASE3","title":"Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial","status":"NOT_YET_RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2025-07-30","conditions":"Rectal Cancer, Rectal Cancer Patients","enrollment":210},{"nctId":"NCT07026422","phase":"PHASE2","title":"Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)","status":"RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2025-05-30","conditions":"Rectal Malignant Neoplasms","enrollment":54},{"nctId":"NCT07020247","phase":"PHASE3","title":"Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2024-11-19","conditions":"Locally Advanced Rectal Cancer (LARC), Immunotherapy, Radiotherapy","enrollment":184},{"nctId":"NCT02896907","phase":"EARLY_PHASE1","title":"Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2016-10-18","conditions":"Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer","enrollment":8},{"nctId":"NCT06923345","phase":"PHASE2","title":"Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-03-31","conditions":"Rectal Cancer, Neoadjuvant Therapies, Immune Checkpoint Therapy","enrollment":80},{"nctId":"NCT06931808","phase":"PHASE4","title":"Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"First Affiliated Hospital of Ningbo University","startDate":"2025-03-01","conditions":"Localized Advanced Rectal Adenocarcinoma","enrollment":20},{"nctId":"NCT04793932","phase":"PHASE3","title":"Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Associazione Italiana per lo Studio del Pancreas","startDate":"2020-11-03","conditions":"Pancreas Ductal Adenocarcinoma","enrollment":261},{"nctId":"NCT02945566","phase":"PHASE2, PHASE3","title":"Can We Save the Rectum by Watchful Waiting or TransAnal Surgery Following (chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Birmingham","startDate":"2017-06-14","conditions":"Adenocarcinoma of the Rectum","enrollment":380},{"nctId":"NCT06894797","phase":"NA","title":"Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.","status":"RECRUITING","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2025-04-01","conditions":"Locally Advanced Rectal Cancer","enrollment":68},{"nctId":"NCT06417476","phase":"PHASE2","title":"Short-course Radiotherapy or Long-course Chemoradiation Followed by MFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer","status":"RECRUITING","sponsor":"Pei-Rong Ding","startDate":"2022-12-12","conditions":"Rectal Neoplasms","enrollment":66},{"nctId":"NCT06210971","phase":"PHASE2","title":"Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer","status":"RECRUITING","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2024-02-01","conditions":"Rectal Cancer","enrollment":60},{"nctId":"NCT06246344","phase":"","title":"Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2023-12-01","conditions":"Rectal Cancer","enrollment":128},{"nctId":"NCT06602375","phase":"NA","title":"The Effect of Manual Physical Therapy and Exercise in Addition to Routine Dental Care in Individuals With Temporomandibular Disorders","status":"RECRUITING","sponsor":"Brooke Army Medical Center","startDate":"2024-09-16","conditions":"Temporomandibular Disorders (TMD)","enrollment":60},{"nctId":"NCT03367299","phase":"PHASE2","title":"Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Gruppo Italiano Malattie EMatologiche dell'Adulto","startDate":"2018-06-08","conditions":"Acute Lymphoid Leukemia, Philadelphia Chromosome-Negative B-Cell Precursor","enrollment":149},{"nctId":"NCT05601505","phase":"PHASE2","title":"Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-02-03","conditions":"Locally Advanced Rectal Carcinoma, Circulating Tumor DNA","enrollment":470},{"nctId":"NCT05000697","phase":"NA","title":"Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait","status":"RECRUITING","sponsor":"Hospital Alemão Oswaldo Cruz","startDate":"2021-07-14","conditions":"Rectal Cancer, Consolidation","enrollment":216},{"nctId":"NCT02387203","phase":"PHASE2","title":"Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mercy Medical Center","startDate":"2015-01","conditions":"Pseudomyxoma Peritonei, Appendiceal Neoplasms","enrollment":80},{"nctId":"NCT04287894","phase":"PHASE1","title":"Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment","status":"TERMINATED","sponsor":"The Netherlands Cancer Institute","startDate":"2018-12-28","conditions":"Stage III NSCLC","enrollment":18},{"nctId":"NCT04715633","phase":"PHASE2","title":"PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2020-12-01","conditions":"Colorectal Cancer, Microsatellite Instability High","enrollment":53},{"nctId":"NCT06462053","phase":"PHASE2","title":"Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-04-01","conditions":"Early Low Rectal Cancer","enrollment":134},{"nctId":"NCT03714490","phase":"PHASE2","title":"MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2018-10-23","conditions":"Rectal Neoplasms","enrollment":200},{"nctId":"NCT04387500","phase":"PHASE2","title":"Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"West China Hospital","startDate":"2021-07-01","conditions":"Carcinoma, Renal Cell, Fumarate Hydratase Deficiency, Immunotherapy","enrollment":41},{"nctId":"NCT06304545","phase":"PHASE2","title":"Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab","status":"NOT_YET_RECRUITING","sponsor":"Harbin Medical University","startDate":"2024-03-15","conditions":"Rectal Cancer","enrollment":48},{"nctId":"NCT05912075","phase":"PHASE1","title":"Preoperative Radiotherapy And ASTX660 in Rectum Cancer","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2023-12-19","conditions":"Locally-advanced Rectal Cancer","enrollment":78},{"nctId":"NCT03722966","phase":"PHASE2","title":"Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)","status":"TERMINATED","sponsor":"University of Oklahoma","startDate":"2020-01-07","conditions":"Smoking Cessation","enrollment":34},{"nctId":"NCT06239870","phase":"PHASE2","title":"Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer","status":"UNKNOWN","sponsor":"Yunnan Cancer Hospital","startDate":"2023-04-01","conditions":"Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer","enrollment":35},{"nctId":"NCT06097416","phase":"PHASE3","title":"Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"St. James's Hospital, Ireland","startDate":"2024-10","conditions":"Rectal Cancer","enrollment":100},{"nctId":"NCT01216202","phase":"","title":"Sexual Function and Wellbeing in Males With Rectal Cancer","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2010-04","conditions":"Rectal Cancer","enrollment":178},{"nctId":"NCT05450029","phase":"PHASE2","title":"Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Yanhong Deng","startDate":"2022-01-01","conditions":"Rectal Cancer","enrollment":51},{"nctId":"NCT06043999","phase":"NA","title":"Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-09-01","conditions":"Chemotherapy Effect, Rectal Cancer","enrollment":392},{"nctId":"NCT02421315","phase":"NA","title":"Overlapping Neural Circuits in Pediatric OCD","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2014-10","conditions":"Obsessive Compulsive Disorder","enrollment":55},{"nctId":"NCT05956639","phase":"PHASE3","title":"Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-06-20","conditions":"Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)","enrollment":100},{"nctId":"NCT05920928","phase":"NA","title":"Comparison of the Clinical Response of Total Neoadjuvant Treatment of Two Methods of Long-term or Short-term Chemoradiotherapy in Rectal Cancer","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2023-09-23","conditions":"Locally Advanced Rectal Carcinoma","enrollment":114},{"nctId":"NCT02640586","phase":"NA","title":"Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI","status":"UNKNOWN","sponsor":"Sun Ying-Shi","startDate":"2016-01-10","conditions":"Rectal Neoplasms","enrollment":1614},{"nctId":"NCT05780294","phase":"PHASE3","title":"A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-04-01","conditions":"Nasopharyngeal Carcinoma, Leucogen, Chemotherapy","enrollment":132},{"nctId":"NCT03299660","phase":"PHASE2","title":"Avelumab With Chemoradiation in Locally Advanced Rectal Cancer","status":"COMPLETED","sponsor":"Peter MacCallum Cancer Centre, Australia","startDate":"2018-04-30","conditions":"Rectal Cancer","enrollment":37},{"nctId":"NCT04754152","phase":"NA","title":"Long-term Effect of θ Burst Magnetic Stimulation on Clinical Symptoms of Alzheimer Disease","status":"COMPLETED","sponsor":"Anhui Medical University","startDate":"2021-04-21","conditions":"Repetitive Transcranial Magnetic Stimulation","enrollment":45},{"nctId":"NCT01558921","phase":"PHASE3","title":"Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2011-06-21","conditions":"Rectal Cancer","enrollment":920},{"nctId":"NCT05673343","phase":"","title":"The Prognostic Impact Of The Neutrophil To Lymphocyte Ratio In Patients With Locally Advanced Rectal Cancer","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-01-04","conditions":"the Prognostic Value of Pre-treatment NLR in Patients With Locally Advenced Rectal Cancer and Post-treatment","enrollment":100},{"nctId":"NCT02104986","phase":"PHASE2","title":"A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent","status":"COMPLETED","sponsor":"Centre Leon Berard","startDate":"2014-05-12","conditions":"Extra Cranial Non Seminomateous Malignant Germ Cell Tumour","enrollment":117},{"nctId":"NCT05352165","phase":"NA","title":"The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer","status":"UNKNOWN","sponsor":"Shanghai Minimally Invasive Surgery Center","startDate":"2023-01-01","conditions":"Neoadjuvant Therapy","enrollment":192},{"nctId":"NCT03957733","phase":"PHASE2, PHASE3","title":"Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.","status":"UNKNOWN","sponsor":"King Abdullah Medical City","startDate":"2017-11-23","conditions":"Rectal Cancer","enrollment":338},{"nctId":"NCT05244200","phase":"NA","title":"Effect of Insulin Staging in the Context of Pharmaceutical Care on Patients With Type 2 Diabetes Mellitus","status":"UNKNOWN","sponsor":"University of Sulaimani","startDate":"2022-01-20","conditions":"Type 2 Diabetes Mellitus","enrollment":100},{"nctId":"NCT03740984","phase":"NA","title":"Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy","status":"TERMINATED","sponsor":"Dr. Horst Schmidt Klinik GmbH","startDate":"2018-02-01","conditions":"Breast Neoplasm, Ovary Cancer","enrollment":81},{"nctId":"NCT03152370","phase":"PHASE1","title":"Preoperative Radiotherapy and E7046 in Rectum Cancer","status":"COMPLETED","sponsor":"Adlai Nortye Biopharma Co., Ltd.","startDate":"2017-05-17","conditions":"Neoadjuvant Therapy in Rectal Cancer","enrollment":29},{"nctId":"NCT02533271","phase":"PHASE3","title":"Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences","startDate":"2015-08","conditions":"Cancer, Rectum","enrollment":600},{"nctId":"NCT04293419","phase":"PHASE2","title":"Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer","status":"UNKNOWN","sponsor":"Grupo Espanol Multidisciplinario del Cancer Digestivo","startDate":"2019-12-18","conditions":"Rectal Cancer","enrollment":58},{"nctId":"NCT01216189","phase":"","title":"Sexual Function and Wellbeing in Females With Rectal Cancer","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2008-06","conditions":"Rectal Cancer","enrollment":142},{"nctId":"NCT02808689","phase":"NA","title":"Functional Medicine in Asthma (FAst) Study","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-09","conditions":"Asthma","enrollment":48},{"nctId":"NCT04621370","phase":"PHASE2","title":"A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer","status":"UNKNOWN","sponsor":"Liz-Anne Lewsley","startDate":"2020-12-07","conditions":"Rectal Cancer, Rectal Adenocarcinoma, Rectal Neoplasms","enrollment":48},{"nctId":"NCT00268528","phase":"","title":"Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-05-30","conditions":"Childhood Acute Lymphoblastic Leukemia in Remission","enrollment":720},{"nctId":"NCT04331626","phase":"PHASE4","title":"Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC","status":"UNKNOWN","sponsor":"Henan Cancer Hospital","startDate":"2020-04","conditions":"Non-small Cell Lung Cancer Metastatic","enrollment":50},{"nctId":"NCT01440413","phase":"NA","title":"Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer","status":"UNKNOWN","sponsor":"Centre Leon Berard","startDate":"2011-12","conditions":"Breast Cancer","enrollment":40},{"nctId":"NCT02241499","phase":"PHASE2","title":"Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.","status":"COMPLETED","sponsor":"Lund University Hospital","startDate":"2014-10","conditions":"Adenocarcinoma of the Esophagus or Esophagogastric Junction","enrollment":29},{"nctId":"NCT01158651","phase":"PHASE2","title":"Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2010-07-10","conditions":"Glioma","enrollment":23},{"nctId":"NCT02272478","phase":"PHASE2, PHASE3","title":"Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations","status":"UNKNOWN","sponsor":"Cardiff University","startDate":"2014-10-30","conditions":"Acute Myeloid Leukaemia, Myelodysplastic Syndrome","enrollment":1600},{"nctId":"NCT01676961","phase":"PHASE2","title":"Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2013-01","conditions":"Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma","enrollment":5},{"nctId":"NCT02680951","phase":"PHASE1","title":"Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2015-12","conditions":"Acute Myeloid Leukemia","enrollment":""},{"nctId":"NCT03204760","phase":"PHASE2","title":"Steroids In The Management Of Acute Asthma Exacerbations In Children, Which Form Is More Suitable?","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-01-01","conditions":"Steroids In Management Of Acute Asthma Exacerbations","enrollment":50},{"nctId":"NCT01721785","phase":"","title":"Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2012-10","conditions":"Rectal Neoplasms, Magnetic Resonance Imaging, Neoplasms Staging","enrollment":307},{"nctId":"NCT01554007","phase":"","title":"Clinical Course of Korean Crohn's Disease Cohort","status":"UNKNOWN","sponsor":"Kyunghee University Medical Center","startDate":"2012-12","conditions":"Crohn's Disease","enrollment":2000},{"nctId":"NCT02811874","phase":"NA","title":"Community Health Workers and Diabetes Education","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2009-02","conditions":"Diabetes","enrollment":118},{"nctId":"NCT01010373","phase":"PHASE2","title":"Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients","status":"SUSPENDED","sponsor":"BioMAS Ltd","startDate":"2015-01","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":12},{"nctId":"NCT00145769","phase":"PHASE3","title":"A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum","status":"COMPLETED","sponsor":"Trans Tasman Radiation Oncology Group","startDate":"2001-07","conditions":"Adenocarcinoma of Rectum","enrollment":326}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"long-course chemotherapy","genericName":"long-course chemotherapy","companyName":"Associazione Italiana per lo Studio del Pancreas","companyId":"associazione-italiana-per-lo-studio-del-pancreas","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Researchers are studying a treatment for locally advanced rectal cancer that involves long-course chemotherapy combined with radiotherapy, with or without immunotherapy using the anti-PD-1 antibody drug Serplulimab. This treatment modality targets proteins, specifically WT1-331 long, which is a protein modality.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}